Bioxyne Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bioxyne Limited with three other companies in this sector in Australia: Biotron Limited (2017 sales of 1.66 million Australian Dollars [US$1.27 million] ), OBJ Limited (1.80 million Australian Dollars [US$1.38 million] of which 100% was Dermaportation & ET Technologies), and Innate Immunotherapeutics Ltd (1.83 million Australian Dollars [US$1.41 million] ).

Sales Analysis. During the year ended June of 2017, sales at Bioxyne Limited were A$2.01 million (US$1.54 million). This is a very small increase of 1.7% versus 2016, when the company's sales were A$1.98 million.